The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS NO.: 1246552-55-5;5-bromoisoxazolo[5,4-b]pyridine. PROPERTIES: This brominated heterocycle presents as a white crystalline solid with a molecular weight of approximately 211.0 g/mol. The 5-bromoisoxazolo[5,4-b]pyridine combines a bromine substituent with a fused isoxazole-pyridine ring system. It exhibits limited aqueous solubility but good dissolution in polar aprotic solvents like DMSO and DMF. Stability characterization reveals sensitivity to nucleophilic aromatic substitution and base-catalyzed ring-opening, necessitating storage at 2-8 degree Celsius in sealed glass containers. Handlers should use powder hoods with HEPA filtration and wear cut-resistant gloves during handling. Skin contact may cause mild irritation requiring thorough washing. Inhalation may induce respiratory tract irritation; treatment includes fresh air and medical evaluation. Eye exposure requires extended rinsing and possible corticosteroid application. Waste should be hydrolyzed with dilute acid prior to disposal. APPLICATIONS: The 5-bromoisoxazolo[5,4-b]pyridine functions as a key intermediate in the synthesis of various pharmaceuticals. Its isoxazole-pyridine framework provides opportunities for directed metalation and cross-coupling reactions. Research teams utilize this compound as a starting material for creating kinase inhibitors and ion channel modulators. The bromine substituent offers opportunities for further diversification in medicinal chemistry. Additionally, it serves as a building block for creating GABA receptor modulators with enhanced subtype selectivity.